Package 70436-025-80

{"route": ["INTRAVENOUS"], "spl_id": "c44f8757-1a09-ab1e-e053-2a95a90a44e1", "openfda": {"nui": ["N0000175980", "N0000175518", "N0000009963"], "unii": ["TN9BEX005G"], "rxcui": ["308769"], "spl_set_id": ["5d9a45c6-e234-4d56-9132-5e24e65852e6"], "pharm_class_epc": ["Anti-coagulant [EPC]", "Direct Thrombin Inhibitor [EPC]"], "pharm_class_moa": ["Thrombin Inhibitors [MoA]"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 VIAL, SINGLE-DOSE (70436-025-80)", "package_ndc": "70436-025-80", "marketing_start_date": "20210630"}, {"sample": false, "description": "10 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 CARTON (70436-025-82)", "package_ndc": "70436-025-82", "marketing_start_date": "20210630"}], "brand_name": "bivalirudin", "product_id": "70436-025_c44f8757-1a09-ab1e-e053-2a95a90a44e1", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION", "pharm_class": ["Anti-coagulant [EPC]", "Direct Thrombin Inhibitor [EPC]", "Thrombin Inhibitors [MoA]"], "product_ndc": "70436-025", "generic_name": "bivalirudin", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bivalirudin", "active_ingredients": [{"name": "BIVALIRUDIN", "strength": "250 mg/1"}], "application_number": "ANDA213078", "marketing_category": "ANDA", "marketing_start_date": "20210630", "listing_expiration_date": "20261231"}